These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 36583782)

  • 21. Clinical application of liquid biopsy in colorectal cancer: detection, prediction, and treatment monitoring.
    Tao XY; Li QQ; Zeng Y
    Mol Cancer; 2024 Jul; 23(1):145. PubMed ID: 39014366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review of Blood-Based Colorectal Cancer Screening: How Far Are Circulating Cell-Free DNA Methylation Markers From Clinical Implementation?
    Worm Ørntoft MB
    Clin Colorectal Cancer; 2018 Jun; 17(2):e415-e433. PubMed ID: 29678513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Four circulating exosomal miRNAs as novel potential biomarkers for the early diagnosis of human colorectal cancer.
    Shi Y; Zhuang Y; Zhang J; Chen M; Wu S
    Tissue Cell; 2021 Jun; 70():101499. PubMed ID: 33550035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer.
    Matsumura T; Sugimachi K; Iinuma H; Takahashi Y; Kurashige J; Sawada G; Ueda M; Uchi R; Ueo H; Takano Y; Shinden Y; Eguchi H; Yamamoto H; Doki Y; Mori M; Ochiya T; Mimori K
    Br J Cancer; 2015 Jul; 113(2):275-81. PubMed ID: 26057451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of
    Siri G; Alesaeidi S; Dizghandi SE; Alani B; Mosallaei M; Soosanabadi M
    J Cancer Res Ther; 2022 Dec; 18(Supplement):S354-S358. PubMed ID: 36510988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum exosomal miR-377-3p and miR-381-3p as diagnostic biomarkers in colorectal cancer.
    Wang L; Song X; Yu M; Niu L; Zhao Y; Tang Y; Zheng B; Song X; Xie L
    Future Oncol; 2022 Mar; 18(7):793-805. PubMed ID: 34854318
    [No Abstract]   [Full Text] [Related]  

  • 27. Circulating tumor DNA detectable in early- and late-stage colorectal cancer patients.
    Yang YC; Wang D; Jin L; Yao HW; Zhang JH; Wang J; Zhao XM; Shen CY; Chen W; Wang XL; Shi R; Chen SY; Zhang ZT
    Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29914973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic and diagnostic applications of exosomes in colorectal cancer.
    Shakerian N; Darzi-Eslam E; Afsharnoori F; Bana N; Noorabad Ghahroodi F; Tarin M; Mard-Soltani M; Khalesi B; Hashemi ZS; Khalili S
    Med Oncol; 2024 Jul; 41(8):203. PubMed ID: 39031221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA-methylation-mediated silencing of miR-486-5p promotes colorectal cancer proliferation and migration through activation of PLAGL2/IGF2/β-catenin signal pathways.
    Liu X; Chen X; Zeng K; Xu M; He B; Pan Y; Sun H; Pan B; Xu X; Xu T; Hu X; Wang S
    Cell Death Dis; 2018 Oct; 9(10):1037. PubMed ID: 30305607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progressive alteration of DNA methylation of Alu, MGMT, MINT2, and TFPI2 genes in colonic mucosa during colorectal cancer development.
    Kang B; Lee HS; Jeon SW; Park SY; Choi GS; Lee WK; Heo S; Lee DH; Kim DS
    Cancer Biomark; 2021; 32(2):231-236. PubMed ID: 34092617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNAs as potential liquid biopsy biomarkers in colorectal cancer: A systematic review.
    Toiyama Y; Okugawa Y; Fleshman J; Richard Boland C; Goel A
    Biochim Biophys Acta Rev Cancer; 2018 Dec; 1870(2):274-282. PubMed ID: 29852194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multimodal analysis of ctDNA methylation and fragmentomic profiles enhances detection of nonmetastatic colorectal cancer.
    Nguyen HT; Khoa Huynh LA; Nguyen TV; Tran DH; Thu Tran TT; Khang Le ND; Le NT; Pham TN; Le MT; Quynh Pham TM; Nguyen TH; Van Nguyen TC; Nguyen TD; Tran Nguyen BQ; Phan MD; Giang H; Tran LS
    Future Oncol; 2022 Nov; 18(35):3895-3912. PubMed ID: 36524960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and evaluation of plasma microRNAs for early detection of colorectal cancer.
    Luo X; Stock C; Burwinkel B; Brenner H
    PLoS One; 2013; 8(5):e62880. PubMed ID: 23690963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA barcode-based detection of exosomal microRNAs using nucleic acid lateral flow assays for the diagnosis of colorectal cancer.
    Kim S; Han J; Park JS; Kim JH; Lee ES; Cha BS; Park KS
    Talanta; 2022 May; 242():123306. PubMed ID: 35189412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating Exosomal miRNAs as Biomarkers for the Diagnosis and Prognosis of Colorectal Cancer.
    Alves Dos Santos K; Clemente Dos Santos IC; Santos Silva C; Gomes Ribeiro H; de Farias Domingos I; Nogueira Silbiger V
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early detection of the major male cancer types in blood-based liquid biopsies using a DNA methylation panel.
    Constâncio V; Nunes SP; Moreira-Barbosa C; Freitas R; Oliveira J; Pousa I; Oliveira J; Soares M; Dias CG; Dias T; Antunes L; Henrique R; Jerónimo C
    Clin Epigenetics; 2019 Dec; 11(1):175. PubMed ID: 31791387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating microRNA testing for the early diagnosis and follow-up of colorectal cancer patients.
    Fesler A; Jiang J; Zhai H; Ju J
    Mol Diagn Ther; 2014 Jun; 18(3):303-8. PubMed ID: 24566942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamic liquid biopsy components as predictive and prognostic biomarkers in colorectal cancer.
    Raza A; Khan AQ; Inchakalody VP; Mestiri S; Yoosuf ZSKM; Bedhiafi T; El-Ella DMA; Taib N; Hydrose S; Akbar S; Fernandes Q; Al-Zaidan L; Krishnankutty R; Merhi M; Uddin S; Dermime S
    J Exp Clin Cancer Res; 2022 Mar; 41(1):99. PubMed ID: 35292091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fecal DNA methylation markers for detecting stages of colorectal cancer and its precursors: a systematic review.
    Raut JR; Guan Z; Schrotz-King P; Brenner H
    Clin Epigenetics; 2020 Aug; 12(1):122. PubMed ID: 32778176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutation-Agnostic Detection of Colorectal Cancer Using Liquid Biopsy-Based Methylation-Specific Signatures.
    Gouda MA; Duose DY; Lapin M; Zalles S; Huang HJ; Xi Y; Zheng X; Aldesoky AI; Alhanafy AM; Shehata MA; Wang J; Kopetz S; Meric-Bernstam F; Wistuba II; Luthra R; Janku F
    Oncologist; 2023 Apr; 28(4):368-372. PubMed ID: 36200910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.